BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND MKL1, BSAC, 57591, ENSG00000196588, Q969V6, MRTF-A
10 results:

  • 1. MKL-1-induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA-mediated glycolysis.
    Wang J; Zhang HM; Dai ZT; Huang Y; Liu H; Chen Z; Wu Y; Liao XH
    Sci Rep; 2022 Dec; 12(1):21283. PubMed ID: 36494481
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. mkl1 regulates hepatocellular carcinoma cell proliferation, migration and apoptosis via the COMPASS complex and NF-κB signaling.
    Liu Z; Sun J; Li C; Xu L; Liu J
    BMC Cancer; 2021 Nov; 21(1):1184. PubMed ID: 34742274
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma.
    Mittermeier C; Konopa A; Muehlich S
    Cells; 2020 Nov; 9(12):. PubMed ID: 33255630
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Rictor promotes cell migration and actin polymerization through regulating ABLIM1 phosphorylation in Hepatocellular Carcinoma.
    Dong X; Feng M; Yang H; Liu H; Guo H; Gao X; Liu Y; Liu R; Zhang N; Chen R; Kong R
    Int J Biol Sci; 2020; 16(15):2835-2852. PubMed ID: 33061800
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Long non-coding RNA PVT1 regulates the migration of hepatocellular carcinoma HepG2 cells via miR-3619-5p/mkl1 axis.
    Liu H; Yin Y; Liu T; Gao Y; Ye Q; Yan J; Ha F
    Bosn J Basic Med Sci; 2021 Apr; 21(2):187-197. PubMed ID: 32156248
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. RASSF1A is required for the maintenance of nuclear actin levels.
    Chatzifrangkeskou M; Pefani DE; Eyres M; Vendrell I; Fischer R; Pankova D; O'Neill E
    EMBO J; 2019 Aug; 38(16):e101168. PubMed ID: 31414556
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma.
    Hermanns C; Hampl V; Holzer K; Aigner A; Penkava J; Frank N; Martin DE; Maier KC; Waldburger N; Roessler S; Goppelt-Struebe M; Akrap I; Thavamani A; Singer S; Nordheim A; Gudermann T; Muehlich S
    Oncogene; 2017 Jun; 36(24):3464-3476. PubMed ID: 28114277
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene-induced senescence.
    Hampl V; Martin C; Aigner A; Hoebel S; Singer S; Frank N; Sarikas A; Ebert O; Prywes R; Gudermann T; Muehlich S
    EMBO Mol Med; 2013 Sep; 5(9):1367-82. PubMed ID: 23853104
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The transcriptional coactivators megakaryoblastic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver cancer 1.
    Muehlich S; Hampl V; Khalid S; Singer S; Frank N; Breuhahn K; Gudermann T; Prywes R
    Oncogene; 2012 Aug; 31(35):3913-23. PubMed ID: 22139079
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. mrtf-a/B suppress the oncogenic properties of v-ras- and v-src-mediated transformants.
    Yoshio T; Morita T; Tsujii M; Hayashi N; Sobue K
    Carcinogenesis; 2010 Jul; 31(7):1185-93. PubMed ID: 20338973
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.